SCHEMBL21828985

SCHEMBL21828985

O=C(Nc1cccc2ccccc12)c1cccc(Cl)c1Cl

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGES O14684 1/20 0.64
RAB9A P51151 4/20 0.64
NPC1 O15118 3/20 0.64
CHRNB2 P17787 1/20 0.61
CHRNB4 P30926 1/20 0.61
CHRNA3 P32297 1/20 0.61
CHRNA4 P43681 1/20 0.61
CYP1A2 P05177 2/20 0.58
CYP2C19 P33261 2/20 0.58
CYP3A4 P08684 1/20 0.58
CYP2D6 P10635 1/20 0.58
CYP2C9 P11712 1/20 0.58
RORC P51449 1/20 0.57
HPGD P15428 1/20 0.57
SMN1; SMN2 Q16637 4/20 0.56
TP53 P04637 2/20 0.56
GAA P10253 2/20 0.56
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
ALDH1A1 P00352 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6357071 0.91 PTGES (0.76) PTGESRAB9ANPC1CHRNB2CHRNB4
Naptalam SCHEMBL8382453 0.85 HSD17B10 (0.58) PTGESRAB9ANPC1CHRNB2CHRNB4
SCHEMBL27491350 0.84 CYP1A2 (0.70) PTGESRAB9ANPC1CHRNB2CHRNB4
SCHEMBL21275460 0.84 RAB9A (0.76) RAB9ANPC1CHRNB2CHRNB4CHRNA3
SCHEMBL11751093 0.83 NPC1 (0.63) PTGESRAB9ANPC1CHRNB2CHRNB4
SCHEMBL21829030 0.81 NPC1 (0.68) PTGESRAB9ANPC1CHRNB2CHRNB4
SCHEMBL8122020 0.81 NPC1 (0.67) RAB9ANPC1CYP1A2CYP2C19RORC
SCHEMBL9407433 0.81 RAB9A (0.58) PTGESRAB9ANPC1CHRNB2CHRNB4
Naptalam SCHEMBL8537412 0.80 HSD17B10 (0.74) RAB9ANPC1CHRNB2CHRNB4CHRNA3
Naptalam SCHEMBL29610802 0.80 HSD17B10 (0.74) RAB9ANPC1CHRNB2CHRNB4CHRNA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210347752-A1 BENZAMIDE DERIVATIVES AS CGAS-STING PATHWAY AGONISTS BARUCH S. BLUMBERG INSTITUTE 2021-11-11 US claimed
CN-112888688-A Benzamide derivatives as CGAS-STING pathway agonists 巴鲁克斯布伦博格研究所 2021-06-01 CN claimed
WO-2020072492-A1 BENZAMIDE DERIVATIVES AS CGAS-STING PATHWAY AGONISTS BARUCH S. BLUMBERG INSTITUTE (US) 2020-04-09 WO claimed
US-12509436-B2 Benzamide derivatives as cGAS-sting pathway agonists BARUCH S. BLUMBERG INSTITUTE (US) 2025-12-30 US disclosed
US-20210347752-A1 BENZAMIDE DERIVATIVES AS CGAS-STING PATHWAY AGONISTS BARUCH S. BLUMBERG INSTITUTE 2021-11-11 US disclosed
US-20210347752-A1 BENZAMIDE DERIVATIVES AS CGAS-STING PATHWAY AGONISTS BARUCH S. BLUMBERG INSTITUTE 2021-11-11 US disclosed
CN-112888688-A Benzamide derivatives as CGAS-STING pathway agonists 巴鲁克斯布伦博格研究所 2021-06-01 CN disclosed
WO-2020072492-A1 BENZAMIDE DERIVATIVES AS CGAS-STING PATHWAY AGONISTS BARUCH S. BLUMBERG INSTITUTE (US) 2020-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12509436-B2 Benzamide derivatives as cGAS-sting pathway agonists STING1, CGAS, IFNAR1 PTGES 3541/4885RAB9A 370/4885NPC1 633/4885
US-20210347752-A1 BENZAMIDE DERIVATIVES AS CGAS-STING PATHWAY AGONISTS STING1, CGAS, MAVS PTGES 1070/4885RAB9A 1646/4885NPC1 1661/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.